Brian J. Abraham

Active 2011–2024

63
Papers
27,753
Citations
49
h-index
61
i10-index

Citations

Citations per year for Brian J. Abraham1983: 1 citations1992: 1 citations2007: 1 citations2010: 1 citations2011: 2 citations2012: 13 citations2013: 49 citations2014: 178 citations2015: 373 citations2016: 447 citations2017: 555 citations2018: 581 citations2019: 1,576 citations2020: 1,866 citations2021: 2,146 citations2022: 1,427 citations2023: 1,181 citations2024: 1,508 citations2025: 701 citations2026: 17 citations1984–1991: no citations, so these years are not shown1993–2006: no citations, so these years are not shown2008–2009: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,111 citing papers, 30.2% of this breakdownChina: 1,844 citing papers, 13.5% of this breakdownUnited Kingdom: 905 citing papers, 6.6% of this breakdownGermany: 833 citing papers, 6.1% of this breakdownFrance: 482 citing papers, 3.5% of this breakdownJapan: 444 citing papers, 3.3% of this breakdownNetherlands: 407 citing papers, 3% of this breakdownCanada: 405 citing papers, 3% of this breakdownItaly: 368 citing papers, 2.7% of this breakdownSpain: 323 citing papers, 2.4% of this breakdownAustralia: 248 citing papers, 1.8% of this breakdownSwitzerland: 248 citing papers, 1.8% of this breakdown
0%30.2%Other 22.1%

Fields

  • Biochemistry, Genetics and Molecular Biology67.8%
  • Medicine21.7%
  • Immunology and Microbiology5.2%
  • Neuroscience1.5%
  • Agricultural and Biological Sciences1.2%
  • Chemistry0.6%
  • Other2%

Topics

  • Genomics and Chromatin Dynamics10.5%
  • RNA Research and Splicing8.6%
  • RNA modifications and cancer5.3%
  • Epigenetics and DNA Methylation4.1%
  • Protein Degradation and Inhibitors3.6%
  • RNA and protein synthesis mechanisms2.8%
  • Other65.1%

Coauthors

All papers

Open in search
  1. Coactivator condensation at super-enhancers links phase separation and gene control

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science 2018 cited by 2,769

  2. Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes

    Authors: , , , , , , , , - Cell 2013 cited by 4,411

  3. Transcription Factors Activate Genes through the Phase-Separation Capacity of Their Activation Domains

    Authors: , , , , , , , , , , , , , , , , , , - Cell 2018 cited by 1,973

  4. Super-Enhancers in the Control of Cell Identity and Disease

    Authors: , , , , , , , - Cell 2013 cited by 3,930

  5. YY1 Is a Structural Regulator of Enhancer-Promoter Loops

    Authors: , , , , , , , , , , , , , , , - Cell 2017 cited by 1,099

  6. Pol II phosphorylation regulates a switch between transcriptional and splicing condensates

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 729

  7. Targeting transcription regulation in cancer with a covalent CDK7 inhibitor

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2014 cited by 908

  8. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element

    Authors: , , , , , , , , , , , , , , - Science 2014 cited by 829

  9. EP300 Selectively Controls the Enhancer Landscape of MYCN -Amplified Neuroblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2021 cited by 163

  10. Mediator Condensates Localize Signaling Factors to Key Cell Identity Genes

    Authors: , , , , , , , , , , , , , , , , , , , , - Molecular Cell 2019 cited by 302

  11. Control of Cell Identity Genes Occurs in Insulated Neighborhoods in Mammalian Chromosomes

    Authors: , , , , , , , , , , - Cell 2014 cited by 949

  12. CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer

    Authors: , , , , , , , , , , , , , , , - Cell 2014 cited by 663

  13. Convergence of Developmental and Oncogenic Signaling Pathways at Transcriptional Super-Enhancers

    Authors: , , , , , , , - Molecular Cell 2015 cited by 506

  14. CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer

    Authors: , , , , , , , , , , , , , , , , - Cell 2015 cited by 493

  15. The long noncoding RNA Wisper controls cardiac fibrosis and remodeling

    Authors: , , , , , , , , , , , , , - Science Translational Medicine 2017 cited by 337

  16. Transcription factor trapping by RNA in gene regulatory elements

    Authors: , , , , , , , , , - Science 2015 cited by 527

  17. Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression

    Authors: , , , , , , , , , - Nature 2016 cited by 527

  18. Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry

    Authors: , , , , , , , , , , , , , , , - Nature Genetics 2018 cited by 302

  19. Models of human core transcriptional regulatory circuitries

    Authors: , , , , , , , - Genome Research 2016 cited by 313

  20. A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer

    Authors: , , , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 231

  21. Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors

    Authors: , , , , , , , , , , , , , , , , , , - Nature Chemical Biology 2016 cited by 372

  22. MYC Drives a Subset of High-Risk Pediatric Neuroblastomas and Is Activated through Mechanisms Including Enhancer Hijacking and Focal Enhancer Amplification

    Authors: , , , , , , , , , , , , , , - Cancer Discovery 2017 cited by 237

  23. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2016 cited by 357

  24. Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2014 cited by 458